Godavari Biorefineries Secures Chinese Patent for Antiviral Compounds Targeting V-ATPase
The Chinese patent approval enhances Godavari’s global biopharmaceutical IP portfolio amid ongoing operational challenges in sugar and ethanol segments
Godavari Biorefineries has been granted a Chinese patent for chemical compounds that inhibit V-ATPase activity to treat viral infections, marking a significant advancement in its biopharmaceutical R&D pipeline. This patent complements existing Japanese and European patents but is unlikely to impact near-term earnings,…